MTOR and colorectal carcinoma: In the present work, we investigated the underlying anticancer mechanism of melatonin using HT-29, SW48, and Caco-2 CRC cells; the mechanism included oxidative stress, ER stress, AMPK, and PI3K/Akt/mTOR pathways.